These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10927157)

  • 41. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
    Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
    Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI mapping of microvascular permeability and tissue blood volume.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; Mann JS; Tomazic S; Brasch RC
    Pflugers Arch; 1996; 431(6 Suppl 2):R263-4. PubMed ID: 8739365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
    Atkin G; Taylor NJ; Daley FM; Stirling JJ; Richman P; Glynne-Jones R; d'Arcy JA; Collins DJ; Padhani AR
    Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI.
    Hoang BH; Dyke JP; Koutcher JA; Huvos AG; Mizobuchi H; Mazza BA; Gorlick R; Healey JH
    Clin Orthop Relat Res; 2004 Sep; (426):32-8. PubMed ID: 15346048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
    Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
    Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
    Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging applications in the evaluation of tumor angiogenesis.
    Neeman M; Provenzale JM; Dewhirst MW
    Semin Radiat Oncol; 2001 Jan; 11(1):70-82. PubMed ID: 11146044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiologic basis of contrast enhancement in breast tumors.
    Knopp MV; Weiss E; Sinn HP; Mattern J; Junkermann H; Radeleff J; Magener A; Brix G; Delorme S; Zuna I; van Kaick G
    J Magn Reson Imaging; 1999 Sep; 10(3):260-6. PubMed ID: 10508285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media.
    Pradel C; Siauve N; Bruneteau G; Clement O; de Bazelaire C; Frouin F; Wedge SR; Tessier JL; Robert PH; Frija G; Cuenod CA
    Magn Reson Imaging; 2003 Oct; 21(8):845-51. PubMed ID: 14599534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Consolino L; Longo DL; Sciortino M; Dastrù W; Cabodi S; Giovenzana GB; Aime S
    Gastric Cancer; 2017 Jul; 20(4):629-639. PubMed ID: 27995483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.
    Kim SH; Lee HS; Kang BJ; Song BJ; Kim HB; Lee H; Jin MS; Lee A
    PLoS One; 2016; 11(12):e0168632. PubMed ID: 28036342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
    Gődény M; Léránt G
    Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance dispersion imaging for localization of angiogenesis and cancer growth.
    Mischi M; Turco S; Lavini C; Kompatsiari K; de la Rosette JJ; Breeuwer M; Wijkstra H
    Invest Radiol; 2014 Aug; 49(8):561-9. PubMed ID: 24691142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.
    Ma L; Xu X; Zhang M; Zheng S; Zhang B; Zhang W; Wang P
    Magn Reson Imaging; 2017 Apr; 37():27-32. PubMed ID: 27840273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation.
    Dafni H; Kim SJ; Bankson JA; Sankaranarayanapillai M; Ronen SM
    Magn Reson Med; 2008 Oct; 60(4):822-33. PubMed ID: 18816866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental evaluation of the vascular effects and transport of an iodinated macromolecular contrast medium.
    Manduteanu I; Corot C; Simionescu N; Meyer D; Simionescu M
    Invest Radiol; 1997 Aug; 32(8):447-52. PubMed ID: 9258732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.
    Bhujwalla ZM; Artemov D; Natarajan K; Solaiyappan M; Kollars P; Kristjansen PE
    Clin Cancer Res; 2003 Jan; 9(1):355-62. PubMed ID: 12538488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial.
    Daldrup-Link HE; Rydland J; Helbich TH; Bjørnerud A; Turetschek K; Kvistad KA; Kaindl E; Link TM; Staudacher K; Shames D; Brasch RC; Haraldseth O; Rummeny EJ
    Radiology; 2003 Dec; 229(3):885-92. PubMed ID: 14576446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.